A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2004
12/14/2004	US6830882 For antiobesity/diabetes agents; drug screening
12/14/2004	US6830765 Extract of green tea containing from 20% to 50% by mass of catechols expressed as epigallocatechol gallate
12/14/2004	US6830760 Glyburide composition
12/14/2004	CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/12/2004	CA2465621A1 Pharmaceutical compositions of atorvastatin
12/09/2004	WO2004106323A1 Method for producing cyclic diamine derivative or salt thereof
12/09/2004	WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004	WO2004106310A1 Novel 3-substituted-1,4-benzodiazepines
12/09/2004	WO2004106290A1 Amino alcohol derivatives, phamaceutical compositions containing the same, and use of both
12/09/2004	WO2004106283A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these
12/09/2004	WO2004106280A1 CaSR ANTAGONIST
12/09/2004	WO2004106276A1 Condensed ring compound
12/09/2004	WO2004105789A1 Grf analog compositions and their use
12/09/2004	WO2004105780A2 Compositions comprising gastrin compounds and their use in diabetes
12/09/2004	WO2004105778A1 Combination consisting of a magnesium preparation having a prolonged release and of another active substance, and use thereof in the fields of cosmetics, therapeutics and/or nutrition
12/09/2004	WO2004105763A2 Use of tyrosine kinase inhibitor to treat diabetes
12/09/2004	WO2004105754A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004	WO2004105752A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
12/09/2004	WO2004105748A1 Amino acid composition and fluid replacement
12/09/2004	WO2004078108A3 Fibrate tablet and method for the production thereof
12/09/2004	WO2004072041A8 Tetrahydroquinolines as agonists of liver- x receptors
12/09/2004	WO2004069194A9 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes
12/09/2004	WO2004067496A9 Crystalline form of nateglinide
12/09/2004	WO2003106474A3 Gangliosides with a modified acyl function
12/09/2004	WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
12/09/2004	WO2003097051A3 Use of compounds that are effective as selective opiate receptor modulators
12/09/2004	WO2003082898A3 Novel analogues of glucose-dependent insulinotropic polypeptide
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040249159 Novel piperidin-2,6-dione disulphate salts and their use for the treatment of stress related affective disorders
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248966 A drug contains melatonin, other melatonergic agents, melatonin agonists and melatonin antagonists, in an effective amount within the range of 0.0025 to 50 mg, and other therapeutic agent; improving the restorative quality of sleep; sustained release
12/09/2004	US20040248951 Aniline derivatives, their manufacture and use as pharmaceuticals
12/09/2004	US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors
12/09/2004	US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
12/09/2004	US20040248937 protein tyrosine phosphatase inhibitors such as N-[(4-{[4,6-bis(4-methoxyphenyl)pyrimidin-2-yl]amino}phenyl)sulfonyl]-N-methyl-L-phenylalanine, used for treatment of metabolic disorders related to insulin resistance or hyperglycemia
12/09/2004	US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004	US20040248934 peroxisome proliferator activator receptor agonists; anticholesterol, antidiabetic agents; 2-Methyl-2-{2-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-carbonyl]-1,2,3,4-tetrahydro-isoquinolin-7-yloxy}-propionic acid
12/09/2004	US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248919 Insulin sensitizers which do not increase triglyceride levels or suppress thyroid hormone axis; such as 7-[3,5-di-tert-butyl-2-(2,2-difluoroethoxy)-phenyl]-4-fluoro-3-methyl-octa-2,4,6-trienoic acid; synthesis; retinoid X receptor (rxr)
12/09/2004	US20040248913 (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators
12/09/2004	US20040248902 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis
12/09/2004	US20040248895 Novel guanidino compounds
12/09/2004	US20040248889 Analgesics; synthesis
12/09/2004	US20040248876 Reducing islet amyloid polypeptide (IAPP) associated deposit; type II diabetes
12/09/2004	US20040248849 3-Aryl-A-oxy substituted propanoic acids and a process for their preparation
12/09/2004	US20040248832 Enhancement of transfection of dna into the liver
12/09/2004	US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders
12/09/2004	US20040248822 Reducing, controlling weight gain; administering estrogen and, or androgen
12/09/2004	US20040248771 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
12/09/2004	US20040248768 Nutritional composition preventing bacterial overgrowth
12/09/2004	US20040248767 Modulating serum amyloid a interaction with tanis and agents useful for same
12/09/2004	US20040248321 Membrane protein for use in treatment and prevention of inflammatory, circulatory, cell proliferative, metabolic and immunological disorders
12/09/2004	US20040248278 Streptococcus expressing lymphocytic protein for use in prevention and treatment of insulin resistance, obesity, autism and attention deficit/hyperactivity disorders
12/09/2004	US20040248266 Method for production of archidonic acid
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder
12/09/2004	US20040248208 Screening method
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040248177 Human hypercholesterolemia causal gene and use thereof
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040247693 Modifying the fatty acid composition of cell membranes of organs and tissues
12/09/2004	US20040247658 Delivery system with increased bioavailability
12/09/2004	US20040247618 Nutrient absorption enhancing compositions and methods
12/09/2004	US20040247604 Anti-inflamatory fatty alcohols and fatty acid esters useful as antigen carriers
12/09/2004	CA2753318A1 Substituted pyrrole derivatives
12/09/2004	CA2527731A1 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
12/09/2004	CA2527691A1 Condensed ring compound
12/09/2004	CA2527195A1 Novel 3-substituted-1,4-benzodiazepines
12/09/2004	CA2527186A1 Compositions comprising gastrin compounds and their use in diabetes
12/09/2004	CA2527168A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004	CA2527039A1 Grf analog compositions and their use
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
12/08/2004	EP1484327A1 Nitrogenous heterocyclic compound and medicine thereof
12/08/2004	EP1484319A1 Chain oligolactic acid thioester
12/08/2004	EP1484316A1 Novel propionic acid derivative
12/08/2004	EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
12/08/2004	EP1484063A2 Method for inhibiting rejection of transplanted tissue
12/08/2004	EP1484055A1 Delivery system with increased bioavailability
12/08/2004	EP1483973A1 Fat or oil composition
12/08/2004	EP1483288A2 Hbm variants that modulate bone mass and lipid levels
12/08/2004	EP1483271A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
12/08/2004	EP1483270A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483265A1 Purine derivatives as kinase inhibitors
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483257A1 Quinazoline compounds useful in therapy
12/08/2004	EP1483247A2 Aryl substituted pyrimidines and the use thereof
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483240A1 Indolamid derivatives which possess glycogen phosphorylase inhibitory activity
12/08/2004	EP1483239A2 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors
12/08/2004	EP1483237A2 Tropane compounds
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists

1 ... 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 ... 1298